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ABSTRACT
Background
Abstinence-plus (comprehensive) interventions promote sexual abstinence as the best means
of preventing HIV, but also encourage condom use and other safer-sex practices. Some critics of
abstinence-plus programs have suggested that promoting safer sex along with abstinence may
undermine abstinence messages or confuse program participants; conversely, others have
suggested that promoting abstinence might undermine safer-sex messages. We conducted a
systematic review to investigate the effectiveness of abstinence-plus interventions for HIV
prevention among any participants in high-income countries as defined by the World Bank.
Methods and Findings
Cochrane Collaboration systematic review methods were used. We included randomized and
quasi-randomized controlled trials of abstinence-plus programs for HIV prevention among any
participants in any high-income country; trials were included if they reported behavioural or
biological outcomes. We searched 30 electronic databases without linguistic or geographical
restrictions to February 2007, in addition to contacting experts, hand-searching conference
abstracts, and cross-referencing papers. After screening 20,070 abstracts and 325 full published
and unpublished papers, we included 39 trials that included approximately 37,724 North
American youth. Programs were based in schools (10), community facilities (24), both schools
andcommunityfacilities(2),healthcarefacilities(2),andfamilyhomes(1).Controlgroupsvaried.
All outcomes were self-reported. Quantitative synthesis was not possible because of
heterogeneity across trials in programs and evaluation designs. Results suggested that many
abstinence-plus programs can reduce HIV risk as indicated by self-reported sexual behaviours.
Of 39 trials, 23 found a protective program effect on at least one sexual behaviour, including
abstinence, condom use, and unprotected sex (baseline n ¼ 19,819). No trial found adverse
programeffectsonanybehaviouraloutcome,includingincidenceofsex,frequencyofsex,sexual
initiation, or condom use. This suggests that abstinence-plus approaches do not undermine
program messages encouraging abstinence, nor do they undermine program messages
encouraging safer sex. Findings consistently favoured abstinence-plus programs over controls
for HIV knowledge outcomes, suggesting that abstinence-plus programs do not confuse
participants. Results for biological outcomes were limited by floor effects. Three trials assessed
self-reported diagnosis or treatment of sexually transmitted infection; none found significant
effects.Limitedevidencefromsevenevaluationssuggestedthatsomeabstinence-plusprograms
can reduce pregnancy incidence. No trial observed an adverse biological program effect.
Conclusions
Many abstinence-plus programs appear to reduce short-term and long-term HIV risk
behaviour among youth in high-income countries. Programs did not cause harm. Although
generalisability may be somewhat limited to North American adolescents, these findings have
critical implications for abstinence-based HIV prevention policies. Suggestions are provided for
improving the conduct and reporting of trials of abstinence-plus and other behavioural
interventions to prevent HIV.
The Editors’ Summary of this article follows the references.
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Although the HIV epidemic is most devastating in middle-
and low-income countries, new infections continue multi-
plying even in countries with many resources for prevention
[1]. The World Health Organization estimated in 2004 that
1.6 million people in high-income countries were living with
HIV [2]; by 2006, approximately 2.1 million individuals in
North America, Western Europe, and Central Europe were
HIV-positive [3]. Sexual behaviour is the most common
transmission route in high-income countries, and primary
prevention efforts remain crucial among high-risk groups
and the general population.
Abstinence-plus programs are popular strategies for HIV
prevention in some high-income countries, particularly in the
United States. These interventions promote sexual abstinence
as the safest behaviour choice to prevent HIV; however,
recognizing that some participants are not abstinent, they
also encourage sexually active participants to use condoms
and other safer-sex strategies. Also known as ‘‘comprehen-
sive’’ and ‘‘abstinence-oriented’’ approaches, abstinence-plus
programs focus primarily on individual-level determinants of
risk behaviour. Typical program components include com-
munication or condom skills practice and HIV education.
Abstinence-plus programs primarily target young people and
are delivered via schools, community-based organizations,
clinics, and media-based campaigns.
Abstinence-plus programs differ from abstinence-only
approaches, which present abstinence as the exclusive means
of risk reduction (without encouraging condom use or other
prevention strategies). Both program types differ from safer-
sex programs, which do not prioritize abstinence over
condom use. Furthermore, both strategies are controversial.
Abstinence-only interventions have been criticized for omit-
ting condom promotion [4–9], while critics of abstinence-plus
programs have suggested that safer-sex promotion can
‘‘undermine the abstinence message’’ [10], confuse program
participants, or encourage sex [11]. Conversely, it is also
important to investigate whether the promotion of absti-
nence can undermine the safer-sex messages of abstinence-
plus programs [12].
This review focuses on studies conducted in high-income
countries. A previous systematic review of abstinence-based
programs in low-income countries has shown minimal to no
effects on behavioural outcomes [13]. No internationally
focused, systematic, and HIV-speciﬁc review of abstinence-
plus programs has been conducted in high-income countries.
Evidence from the developing world may not apply to more
afﬂuent countries because of epidemiological, structural, and
methodological differences [14,15]. Abstinence-plus pro-
grams might be implemented or evaluated differently in
high-income economies, particularly given differences in risk
groups, resource availability, and HIV prevalence. We focused
on high-income countries as a means of limiting hetero-
geneity and producing more speciﬁc results.
The scope and methodology of this review are unique.
Prior reviews in high-income countries have examined
abstinence-plus interventions alongside abstinence-only in-
terventions [16,17], alongside safer-sex programs [18–20], or
in analyses of all three program types [12,21–33]. These
strategies can make it difﬁcult to determine which programs
used an abstinence-plus hierarchy. Four reviews have
suggested that abstinence-plus programs can reduce sexual
risks [17,34–36], but these reviews are limited: all four were
limited to US and Canadian adolescents, three focused on
pregnancy instead of HIV [17,34,35], three included quasi-
experimental program evaluations [34–36], and none in-
cluded evidence from trials completed since 2004.
Evidence for abstinence-plus programs has immediate
implications for public health in high-income countries,
which encompass marked inequalities in income, health, and
HIV prevalence [37]. The subgroups at highest risk encounter
a number of structural and social risk factors [38], such as
discrimination and poverty [39,40]. In the United States, for
example, HIV infection is concentrated among African
American and Hispanic minorities, young people, low-income
urban residents, and rural Southern populations [1]. Our
review was designed to identify studies among both privileged
and underprivileged groups in high-income countries.
This review sought to identify, appraise, and synthesize
evaluations of abstinence-plus interventions for HIV pre-
vention in high-income countries. This version complements
our full Cochrane systematic review [41,42] and our prior
study of abstinence-only interventions for HIV prevention in
high-income countries [43,44], which found that abstinence-
only programs neither decrease nor exacerbate HIV risk in
high-income settings.
Methods
Eligibility Criteria
Eligibility criteria are listed in Box 1 and further clariﬁed
in this section.
Inclusion criteria. We included randomized and quasi-
randomized controlled trials. Quasi-randomized controlled
trials approximate randomization by using a method of
allocation that is unlikely to lead to consistent bias, such as
alternating participants. We made no exclusions by type of
control group. We included trials that took place among any
participants of negative or unknown serostatus in any high-
Box 1. Summary of Eligibility Criteria
Inclusion criteria
1. Randomized or quasi-randomized controlled trial
2. Trial took place in a high-income economy (defined by the World
Bank)
3. Participants were of unknown or negative HIV status
4. At least one trial arm received an abstinence-plus intervention (i.e., an
intervention that emphasized sexual abstinence as the most effective
means of HIV prevention, but also actively promoted safer sex)
5. HIV prevention was a stated program goal
6. Trial reported a biological or behavioural outcome
Exclusion criteria
1. Trial did not use a randomized or quasi-randomized controlled design
2. Trial did not take place in a high-income economy
3. All participants were known to be HIV-positive
4. No trial arm received an abstinence-plus intervention
5. HIV prevention was not a program goal
6. Trial did not report a biological or behavioural outcome
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World Bank as those with a gross national income per capita
of US$10,726 or higher [45], listed in Text S1.
Interventions were any efforts that encouraged sexual
abstinence as the most effective means of HIV prevention,
but also promoted safer-sex strategies such as condom use or
partner reduction. Although deﬁnitions of terms such as
‘‘abstinence’’ and ‘‘sex’’ vary and are often not speciﬁed [46–
51], trials were included if programs encouraged participants
to reduce, delay, or stop sexual activity. Sexual activity could
mean vaginal sex, oral sex, anal sex, or any combination
thereof. We understood ‘‘abstinence’’ to mean refraining
from sexual activity whether it is protected or unprotected.
Trials were included if HIV prevention was a stated program
goal. Upon discussion with the Cochrane HIV/AIDS Group,
we included trials of programs that aimed to prevent both
pregnancy and HIV, as well as trials of programs that aimed
only to prevent HIV. We made no exclusions by the type of
organization or facilitators delivering the program.
We extracted outcome data for biological outcomes (e.g.,
HIV incidence), behavioural outcomes (e.g., unprotected
vaginal sex), and HIV/AIDS-related knowledge. We included
same-sex sexual behaviour outcomes.
Exclusion criteria. Because we were interested in primary
prevention of HIV infection, trials limited to HIV-positive
participants were excluded. No exclusions were made by any
other participant characteristicwithinhigh-income countries,
including age.
We excluded trials that focused exclusively on pregnancy
prevention without listing HIV prevention as a program goal.
Programs that focus only on pregnancy may neglect the HIV-
related risks of oral sex, anal sex, same-sex sexual activity, and
nonsexual means of transmission. Including trials of these
programs might have augmented statistical heterogeneity or
masked the effects of programs that did aim to prevent HIV.
Trials that did not report a biological or behavioural
outcome were excluded; although knowledge, intentions, and
attitudes can mediate intervention effects [27,52], they may
be less reliable indicators of behaviour or HIV risk [53–58].
Information Sources
Our search was designed to identify published and
unpublished program trials. We searched 30 electronic
databases from January 1980 to February 2007 (Box 2).
Electronic searches were not restricted by country, geogra-
phy, economic characteristics, participant group, outcome
measure, or language of publication. We also searched
libraries of international agencies involved with HIV pre-
vention (e.g., UNAIDS, WHO, CDC) and hand-searched
relevant conference abstracts from 2000 onward (i.e., Interna-
tional AIDS Conference, meeting of the International Society
for Sexually Transmitted Diseases Research, Conference on
Retroviruses and Opportunistic Infections, the Abstinence
Education Evaluation Conference, and the US National HIV
Prevention Conference). We searched for unpublished and
ongoing research by contacting ﬁeld experts and cross-
referencing papers.
Search
We developed our search strategy in consultation with the
Cochrane HIV/AIDS Group and additional trial search
experts. We included terms speciﬁc to HIV, abstinence-based
interventions, and comparative study designs. Our PubMed
search is included in Text S2 and was modiﬁed as needed for
other databases; database-speciﬁc search strategies appear in
the forthcoming Cochrane review and are available from the
authors.
Our search was designed to identify program trials
measuring any biological, behavioural, cognitive, attitudinal,
or other outcome; we excluded trials without behavioural or
biological outcomes only after examining full reports. To
heighten sensitivity, our search was designed to identify trials
of both abstinence-only and abstinence-plus programs. We
reviewed full program descriptions before excluding trials of
abstinence-only programs and trials of abstinence-plus
programs that did not aim to prevent HIV.
Data Collection
Two reviewers independently assessed all abstracts for
inclusion, resolving disagreements by discussion and referral
to the third reviewer. Reviewers were not blinded to any
aspect of the trials. If any reviewer believed a record to be
relevant, a full-text copy was retrieved. Trialists were
contacted for clariﬁcation as needed.
Using standard forms, two reviewers independently ex-
tracted data and assessed evaluations for methodological
quality. Where several reports of a single evaluation existed,
data were extracted from all available reports. Disagreements
were resolved by discussion and referral to the third reviewer.
Multiple attempts were made to contact trialists for missing
data, but nonresponse and data loss by trialists were common.
Assessment of Trial Quality
We assessed methodological quality following the Cochrane
Handbook [59], and we highlighted attrition as a particular
limitation of any trials with a total dropout exceeding 33% of
baseline enrolment. Where available, we also assessed
information about cost, acceptability, and implementation
(i.e., program design, actual delivery by clinicians, actual
uptake by participants, and context [60]). Additional details
of our methods are provided in the Cochrane review [41,42].
Analysis and Presentation of Results
All trials were summarized in Review Manager (RevMan)
version 4.2 (Cochrane Information Management System,
http://www.cc-ims.net/RevMan) where possible. We deter-
mined that quantitative synthesis was inappropriate because
of data unavailability, lack of intention-to-treat analyses, and
heterogeneity in programs, clinical settings, control groups,
outcome measures, and evaluation designs. Individual trial
results are presented as derived from RevMan. Where we
were unable to reanalyze data, we report results from the
primary trials. When our reanalysis differed from published
trial reports (speciﬁed in the discussion), we report the
reanalyzed results. Data limitations made it impossible to
statistically test for publication bias.
When trials used cluster randomization, we followed
Box 2. Electronic Databases Searched
ADOLEC, AIDSLINE, AMED, ASSIA, BiblioMap, BIOSIS, BNI, Catalog of US
Government Publications, CHID, CINAHL, CENTRAL (Cochrane Central
Register of Controlled Trials), DARE, Dissertation Abstracts International,
EMBASE, ERIC, EurasiaHealth Knowledge Multilingual Library, Global
Health Abstracts, HealthPromis, HMIC, PAIS, Political Science Abstracts,
PsycINFO, PubMed, RCN, SCISEARCH, SERFILE, SIGLE, Social Services
Abstracts, Sociological Abstracts, TRoPHI
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Johnson et al. [61] to adjust for intraclass correlation. Three
evaluations reported trial-speciﬁc intraclass correlation co-
efﬁcients, which we used in our analyses for those trials [62–
64]. We were unable to obtain trial-speciﬁc intraclass
correlation coefﬁcients or raw data for the remaining
cluster-randomized trials; we therefore followed the prece-
dent of using intraclass correlation coefﬁcients of 0.015 for
school-based evaluations and 0.005 for community-based
evaluations [61].
Ethical Approval
This review dealt entirely with secondary sources. Ethical
approval was secured through the Department of Social
Policy and Social Work, University of Oxford.
Results
The search retrieved 20,070 records (i.e., citations and
abstracts), of which 330 were deemed potentially relevant
evaluations by any reviewer (Figure 1). We successfully
obtained full versions of 325 reports. After excluding reports
based on study design, intervention description, and out-
comes of interest, we included 39 trials [62–100] from 37
separate primary papers. Seven trials were unpublished
[71,73,76,80,84,89,100], and conference presentations consti-
tuted the primary source of information for three evaluations
[71,80,84]. We included conference presentations when we
were able to obtain missing data from authors or when there
was no evidence of selective reporting of results. Authors
were contacted on multiple occasions for missing informa-
tion. Data were also extracted from supplementary papers
where possible (Danella, et al. unpublished data and [101–
122]).
Description of Studies
Included studies are described in Table S1 and Table 1.
Participants. Despite our international search, all 39 trials
included youth only from the US, Canada, and the Bahamas.
Together, the trials enrolled approximately 37,724 partic-
ipants at baseline (median enrolment ¼ 535, totals were
approximated for several studies with nonspeciﬁc reporting).
Mean participant ages for individual trials ranged from 11.3
[95] to 19.3 y [75], with a median of 14.0 y across trials. Twenty-
nine trials enrolled primarily minority participants [62–
70,73,74,76–84,88–91,93,95,96,98,99], and 18 indicated that
participants were of lower socioeconomic status than the
general population [62–65,70,73,74,77–79,84,88–91,95,96,99].
Interventions. Every intervention promoted sexual absti-
nence and condom use for HIV prevention, presenting
abstinence as the most effective choice. Speciﬁc behavioural
and temporal deﬁnitions of ‘‘abstinence’’ (e.g., ‘‘refraining
from oral, anal, and vaginal intercourse until marriage’’) were
rarely provided. The majority of programs were school-based
(ten programs [65,67–69,75,83,84,87,99,100]) or community-
based (24 programs [62–64,70,71,73,74,76–82,85,86,89–95,98]),
and all but three interventions [66,72,96] took place in group
settings. Pregnancy prevention was emphasised along with
HIV prevention in 15 programs [62,65,67–69,72,74,83–90]; the
remaining programs targeted HIV only. Exposure ranged
from 30 min [66] to 2,250 program hours over 3 y [89]
(median exposure ¼ approximately 10.5 h). Program facili-
tators were most commonly adults (29 programs [62,64,66,68–
73,76,77,79,80,82,84–99]) or both adults and peers (six
programs [63,65,67,74,78,100]).
Several programs were represented in multiple evaluations.
These included Be Proud! Be Responsible! (eight trials [76–
82,98]), Becoming a Responsible Teen (four trials [91–94]),
Focus on Kids (four trials [64,71,95,97]), and the ImPACT
parental monitoring program (two trials [64,96]).
Study design. Under-reporting hindered assessment of meth-
odological quality. Five studies were quasi-randomized con-
trolled trials [72,74,85–87]; all other trials reported using ran-
dom assignment, but only ten reported the method of generating
the allocation sequence [62,64,71,78,79,84,89,95,96,98]. No
systematic differences were observed between the results of
quasi-randomized and randomized controlled trials. Clusters
of participants (e.g., schools) were randomized in 21 trials
[62–65,67–70,73,74,80,83,84,87,88,92,94,95,97,99,100], of
which 14 reported analyses that accommodated the blocked
unit of randomization [62–64,67–70,73,80,83,84,87,88,94].
Attrition at ﬁnal follow-up ranged from 0% [92] to 58%
[69], with a median ﬁnal attrition of 20% of baseline
enrolment. Final attrition exceeded 33% in eight trials
[63,64,68,69,81,82,99,100]. Almost every trial analyzed partic-
ipants in their original arms without imputing data for
dropouts (i.e., complete case analyses [123]), making results
vulnerable to attrition bias. There were ﬁve exceptions: one
Figure 1. Flow Chart of Search Results
doi:10.1371/journal.pmed.0040275.g001
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Abstinence-Plus HIV Preventionanalyzed participants by program exposure [88], three had no
attrition or used intention-to-treat procedures that imputed
data for dropouts [68,92,99], and analytic procedures for one
were unclear [80].
Control groups varied as described in Table S1. The use
of ‘‘usual care’’ controls was problematic, as it was often
unclear what services these groups actually received. In
15 trials, several treatment arms that each received a
different abstinence-plus intervention were included
[62–64,70,74,76,78,87,88,91,92,94,95,97,99]; in most of these,
one arm was enhanced by an extra component (e.g.,
community service or skills training). Many trials used an
attention control group, which consisted of a program that
was equal in format and duration to the experimental
program, but was not an abstinence-plus intervention. Only
one trial explicitly compared an abstinence-plus program
against an abstinence-only and a safer-sex intervention [75].
Outcome measures. All outcomes were self-reported. Eight
trials used computers or audio computer assisted self-
interviewing (ACASI) technology to gather data
[63,64,70,73,84,95–97], one trial collected outcome data by
phone [66], and the remaining trials used written surveys or
did not specify methods of data collection. Limitations of
self-reported data have been analyzed elsewhere with respect
to adolescent sexual behaviour [55,124–135]. Recent inves-
tigations (with exceptions [136]) have suggested that ACASI
technology minimizes self-report bias among adolescents
[137–139], but there were too few ACASI trials in this review
to observe differences in results by data collection method.
As presented in Table 2 and Figure 2, we classiﬁed follow-
up assessments as short-term (,6 mo after baseline), medium-
term (6–11 mo), and long-term ( 12 mo). Median ﬁnal
assessment time was 12 mo after baseline. Follow-up assess-
ments took place at a wide variety of times after interventions
ended, and trials varied in the recall periods over which
sexual behaviours were assessed (e.g., over the last 3 mo, ever).
Twenty trials could be partially or completely reanalyzed in
RevMan [62–64,66,70,74,77–79,83,85–87,89,90,92,95,97–99].
The outcomes of greatest relevance to HIV risk (i.e., HIV
infection, sexually transmitted infection [STI], and unpro-
tected sexual behaviours) were underutilized. No trial
assessed HIV incidence. Seven trials assessed self-reported
STI or pregnancy [64,66,69,74,83,88,89], which are vulnerable
to ﬂoor effects (i.e., incidence rates are so low that trials may
be underpowered to ﬁnd signiﬁcant differences between
groups) and underreporting due to unknown status. An
additional trial used records to assess the receipt of STI
treatment [92].
Every trial reported at least one behavioural outcome. Nine
trialsassessedoraloranalsexacts[64,66,70,77,79,84,91,93,100],
but three reported these only in summary measures of oral,
anal, and vaginal intercourse [66,70,84]. Only three trials
reported speciﬁc deﬁnitions of ‘‘sex’’ (e.g., ‘‘a boy’s penis in
your vagina/your penis in a girl’s vagina’’ [76]), all of which
signiﬁed vaginal intercourse [68,76,98]. Given this trend, we
classiﬁed results for nonspeciﬁc deﬁnitions of ‘‘sex’’ as vaginal
sex. No trial reported same-sex sexual behaviour outcomes.
Biological Outcomes
Table 2 presents odds ratios and 95% conﬁdence intervals,
where calculable, for biological outcomes. No trial observed a
signiﬁcantly adverse biological effect. In these results, n refers
to the number of participants included in the analyses and is
not necessarily equivalent to the number enrolled at baseline
or retained at follow-up. Some totals are approximated due
to nonspeciﬁc reporting in primary trials.
Table 2. Trials Reporting Biological Outcomes
Study Gender n Control STI Diagnosis or Treatment
(n ¼ 1,734)
Pregnancy Incidence
(n ¼ 3,672)
,6 mo 6–11 mo  12 mo ,6 mo 6–11 mo  12 mo
Boekeloo
1999 [66]
M/F 219 UC 1.15 (0.07–18.68) 0.15 (0.01–2.98) — 0.23 (0.01–4.76) 0.17 (0.02–1.47) —
Coyle
2006 [69]
M/F 988 UC — — — — 0.61 (0.33–1.12) 0.84 (unclear),
p ¼ 0.61
Ferguson
1998 [74]
F 63 NE — — — Not estimable
(no events)
——
Kirby
1997 [83]
M/F 2,099 UC 1.38 (0.44–4.38) — 0.80 (0.21–3.00) 1.54 (0.59–4.01) — 0.78 (0.29–2.11)
O’Donnell
2002 [88]
M/F 225 NE — — — — — Means, % females ¼
6.8, 10.3, 18.5.
Means, % males ¼
0.0, 9.1, 6.5.
Philliber
2001 [89]
M/F 1,163 UC — — — — — Females 0.52 (0.34–0.81)*;
males 0.89 (0.48–1.66)
St. Lawrence
1995 [92]
M/F 34 NE 0.11 (0.01–1.09) — — — — —
Wu 2003 [64] M/F 817 NE — — — — — 0.53 (0.31–0.90)*
Results are expressed as odds ratios with 95% confidence intervals. Odds ratios , 1 indicate a protective intervention effect. For each outcome n refers to the total number of participants
analyzed at any follow-up. Where no value appears, the outcome was either not measured or not reported. All results were reanalyzed in RevMan software where possible, controlling for
clustering. Coyle 2006 [69] assessed pregnancy since baseline among participants reporting sexual activity in the previous 3 mo, reporting an odds ratio without confidence intervals.
Results for O’Donnell 2002 [88] are expressed as means for the following groups: 2 y of program exposure, 1 y, and 0 y. Insufficient information was available to calculate significance or
odds ratios. Results for Wu 2003 [64] are expressed for the comparison of both FOK þ ImPACT arms combined (conditions #1 and #2 in Table S1) versus the FOK-only control.
*Significant at p , 0.05.
doi:10.1371/journal.pmed.0040275.t002
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Abstinence-Plus HIV PreventionFigure 2. Trials Reporting Behavioural Outcomes and HIV/AIDS Knowledge
For each outcome n refers to the total number of participants analyzed at any follow-up. Where no symbol appears, the outcome was either not
measured or not reported. No harms were observed. All results were reanalyzed in RevMan software where possible, controlling for clustering. If two or
more data points fell into the same follow-up range (e.g., 12 mo and 24 mo assessments), a significant effect at any follow-up is reported. If an outcome
was measured more than one way (e.g., percentage of condom-protected intercourse occasions, condom use at last intercourse), a significant effect for
any definition is reported.
*Attn, attention-matched program that did not focus on HIV prevention; Info, information about HIV; NE, ‘‘nonenhanced’’ program version; None, no
treatment; UC, usual care.
doi:10.1371/journal.pmed.0040275.g002
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Abstinence-Plus HIV PreventionTwo trials measured self-reported STI diagnosis by a doctor
or nurse [66,83], reporting data for 1,700 participants at any
follow-up. Neither found signiﬁcantly protective intervention
effects compared to usual care, although nonsigniﬁcant
differencesfavouredtheabstinence-plusprograms.Asimilarly
nonsigniﬁcant difference was observed in a third trial (n¼34),
which assessed participants’ receipt of STI treatment [92].
Limited evidence suggested that abstinence-plus programs
can reduce pregnancy incidence. Seven trials assessed self-
reports of having or causing a pregnancy, with analyses
representing 3,672 participants [64,66,69,74,83,88,89]. One
trial discovered a signiﬁcantly protective long-term effect
compared to usual care (n¼941), although subgroup analyses
found signiﬁcance among girls only (n ¼ 519) [89]. Another
found a signiﬁcantly protective effect compared to a non-
enhanced program version (n¼494) [64]. A third trial did not
report signiﬁcance, but long-term ﬁndings suggested that
students who participated in a school-based curriculum with
community service were less likely to report pregnancy than
students without service involvement (n ¼ 195) [88]. The
remaining four trials found no signiﬁcant effects (n ¼ 2,053)
[66,69,83].
Behavioural Outcomes
Every trial reported at least one behavioural outcome,
and 23 trials found a signiﬁcantly protective intervention
effect on any sexual risk behaviour [62–69,71,73,74,77–
80,84,85,88,90,91,94,95,98]. No trial observed an adverse effect
on any behavioural outcome. Figure 2 presents each trial’s
ﬁndings on the most commonly reported outcome measures.
Less commonly reported outcomes appear in text only.
Incidence and frequency of unprotected sex. Three trials
assessed participants’ self-reported incidence of unprotected
vaginal sex (n , 2,495), using attention control groups
[73,78,80]. Two trials found signiﬁcantly protective effects at
12 mo follow-up. One assessed lifetime incidence of unpro-
tected sex among sexually experienced participants (n , 277)
[73]; the other assessed unprotected sex in the past 3 mo,
ﬁnding protective effects only among participants who were
sexually experienced at baseline (n ’ 69) [78]. The third trial
found no signiﬁcant effect at 12 mo follow-up (n ’ 1,707) [80].
Participants’ self-reported frequency of unprotected vagi-
nal sex was assessed in 12 trials (n ¼ 4,270) [67,69,76–
79,81,82,91,93,94,98]. Six found protective intervention ef-
fects compared to attention controls (n ¼ 762) [77,78,98],
information about HIV (n ¼ 1,371) [67], usual care (n ¼ 412)
[69], or a nonenhanced program version (n¼159) [94]. Long-
term effects in one trial were signiﬁcant only among
participants who reported sexual experience at baseline
(n ’ 69) [78]. The remaining six trials found no signiﬁcant
effects (n ¼1,353) [76,79,81,82,91,93].
In two trials participants’ self-reported frequency of
unprotected anal sex was assessed (n ¼ 537), and both
evaluated versions of the Becoming a Responsible Teen
program [91,93]. One took place in a juvenile reformatory
and found no signiﬁcant program effects approximately 7
mo after baseline compared to an attention control (n¼312)
[93]. The other took place in a community-based organiza-
tion and found a signiﬁcantly protective effect over a 14 mo
follow-up, compared to a nonenhanced version (n¼225) [91].
This was also the only evaluation to assess frequency of
unprotected oral sex, discovering a signiﬁcantly protective
long-term effect (n ¼ 225).
Incidence and frequency of all sex. Incidence of any
(protected or unprotected) vaginal sex was evaluated in 21
trials (n ’ 13,208) [64,66,68,71,72,74,76–79,81,82,85–88,94,96–
99]. Signiﬁcantly protective effects at any time point were
found in ﬁve trials compared to no treatment (n ¼ 55) [85],
attention controls (n¼356) [78], usual care (among males only,
n ¼ 1,412) [68], or a nonenhanced program version (n ¼ 414)
[88,94]; the remaining 16 trials found no signiﬁcant effects
(n¼9,379) [64,66,71,72,74,76,77,79,81,82,86,87,96–99].
Frequency of recent vaginal sex was reported in 13 trials
(n ¼ 8,524) [66–69,75–78,80–83,90]. In ﬁve trials signiﬁcantly
protective effects were observed at any time point compared
to attention controls (n¼169) [77,78], information about HIV
(n¼95) [90], or usual care (n¼1,905) [68,69]. Protective effects
in one trial using an attention control were signiﬁcant only
among participants who were sexually experienced at base-
line (n ’ 69) [78]. The other eight trials found no signiﬁcant
effects (n ¼ 4,371) [66,67,75,76,80–83].
Incidence of anal sex was reported in three trials (n¼1,091)
[64,77,79]. Two compared versions of Be Proud! Be Respon-
sible! to attention controls, assessing anal sex in the past 3 mo;
each found a protective effect at longest follow-up, which was
3 mo in one trial (n¼117) [77] and 6 mo in the other (n¼460)
[79]. These trials also assessed frequency of anal sex; one
found a protective effect at 6 mo follow-up (n¼460) [79]. The
third trial compared three active interventions: the Focus on
Kids program with parental monitoring and booster sessions,
the program with parental monitoring only, and the program
without parental monitoring or boosters [64]. At 24 mo
follow-up, no pairwise comparison showed a signiﬁcant
program effect on anal sex in the past 6 mo (n ¼ 494).
One trial reported frequency of oral sex, comparing the
Becoming a Responsible Teen program to an attention
control; ﬁndings were nonsigniﬁcant approximately 7 mo
after baseline (n ¼ 312) [93].
In four trials incidence of any recent oral, anal, or vaginal
sex was reported (n ¼ 5,084) [66,84,91,100]. Two trials found
protective effects: one compared to usual care at 5 mo follow-
up (n ¼ 1,206) [84], and one compared to a nonenhanced
program version at 14 mo follow-up (n ¼ 225) [91]. The
remaining two trials found no signiﬁcant effects compared to
usual care (n ¼ 3,653) [66,100].
One trial assessed the incidence of ‘‘casual sex’’ at 3.5 mo
follow-up (n¼34) [92]; although results favoured the addition
of skills training to the information-focused Becoming a
Responsible Teen program, ﬁndings did not reach signiﬁ-
cance when analysed in RevMan. Another trial of the same
program assessed frequency of casual sex approximately 7 mo
after baseline (n ¼ 312), ﬁnding no signiﬁcant effects
compared to an attention control [93].
Number of partners. In 13 trials participants’ number of
sexualpartnerswasassessed[66–69,75,77,79,83,91,93,94,98,100].
Any deﬁnition of ‘‘sexual partner’’ was accepted for this
outcome. Analyses represent at least 7,495 but fewer than
10,513 participants; one large trial restricted analyses to
sexually experienced participants without reporting the size
of this subgroup [100]. Four evaluations found signiﬁcantly
protective effects at any follow-up compared to attention
controls (n ¼ 665) [77,98], usual care (n ¼ 1,412) [68], or a
nonenhanced program version (n ¼ 159) [94]. The remaining
PLoS Medicine | www.plosmedicine.org September 2007 | Volume 4 | Issue 9 | e275 1478
Abstinence-Plus HIV Preventionnine trials found no signiﬁcant effects (3,842 , n , 6,860)
[66,67,69,75,79,83,91,93,100].
Two school-based trials (n¼1,842) reported the number of
partners with whom participants reported unprotected sex
[67,69]. One trial found signiﬁcantly protective effects
among all participants at 19 mo and 31 mo follow-up
compared to an information control (n ¼ 1,371) [67];
repeated measures analyses by gender found signiﬁcance
among males only (n ¼ 658). The other trial found no
signiﬁcant effects at 6, 12, or 18 mo follow-up compared to
usual care (n ¼ 471) [69].
Condom use. In 26 trials a measure of condom use was
reported [62–69,71,76–78,80–83,87,89,91,93–95,97–100].
Analyses represent at least 5,100, but fewer than 14,641
participants; nine trials did not report the exact number of
participants analyzed [65,68,71,76,80,91,93,94,100]. A signiﬁ-
cantly protective effect was reported by 14 trials at any
follow-up compared to no treatment (n , 500) [71],
attention controls (378 , n , 2,085) [77,78,80,98], informa-
tion about HIV (n ¼ 1,436) [62,63,67], usual care (n ¼ 515)
[66,69], or a nonenhanced program version (n , 695)
[64,91,94,95]. The remaining 12 trials found no signiﬁcant
effects (2,432 , n , 9,382) [65,68,76,81–83,87,89,93,97,99,100].
Notrialassessedtheuseofmaleandfemalecondomsseparately.
An additional trial assessed the absolute number of times
that all participants used condoms at 6 wk follow-up, ﬁnding
no signiﬁcant effects in an ANOVA comparing abstinence-
plus, abstinence-only, and safer-sex programs against a no-
treatment control (n ¼ 388) [75]. A post-hoc test found that
safer-sex program participants reported using condoms on
signiﬁcantly more occasions than abstinence-plus program
participants (n ’ 194). However, the trial did not relate the
data to the number of times participants had sexual
intercourse, making it impossible to say whether this effect
suggests beneﬁt (e.g., fewer sex acts) or harm (e.g., a lower
percentage of condom-protected occasions).
Sexual initiation. Sexual initiation, virginity, or ‘‘ever had
sex’’ was assessed in 19 trials (n ’ 20,367) [62,63,65,67–
70,73,74,83–89,97,99,100]. In four a signiﬁcantly protective
program effect was found at any time point compared to usual
care (n ¼ 1,683) [65,68], or a nonenhanced program version
(n ¼ 277) [74,88]. The other 15 trials found no signiﬁcant
effects (n ’ 16,728) [62,63,67,69,70,73,83–87,89,97,99,100].
Knowledge, Cost, and Acceptability
A measure of HIV/AIDS knowledge was reported by 24
trials (n ’ 20,904) [62,66–72,74,76–79,81–83,91–95,97,99,100].
In 20 trials (n ’ 19,364) it was observed that abstinence-plus
program participants reported signiﬁcantly greater HIV/
AIDS knowledge when compared to various controls [62,66–
72,74,76–79,81–83,91,93,99,100]. In one trial, participants in a
nonenhanced program version (without peer counselling)
demonstrated greater knowledge than participants in the
enhanced version at 3 mo follow-up (n ¼ 52) [74]. The four
trials with nonsigniﬁcant ﬁndings compared an abstinence-
plus program to a nonenhanced program version (n ¼ 494)
[92,94,95], or used an attention control in an area with pre-
existing HIV education (n ¼ 938) [97].
Insufﬁcient cost data were available to assess the overall
cost-beneﬁt of abstinence-plus interventions. Where infor-
mation about program acceptability was reported (23 trials),
evaluations consistently indicated high levels of acceptability
and participant satisfaction [62,67–69,73,76–79,84–95,98,100].
Discussion
The 39 included trials (baseline n ’ 37,724) showed no
evidence that abstinence-plus programs increase HIV risk
among youth participants in high-income countries, and
multiple evaluations found that the programs can decrease
HIV risk. In 24 trials (baseline n ¼ 20,982) signiﬁcantly
protective program effects were observed for behavioural
[62–69,71,73,74,77–80,84,85,88,90,91,94,95,98] or biological
[64,89] outcomes.
This review found no conclusive evidence that abstinence-
plus programs can affect STI incidence and found limited
evidence suggesting that abstinence-plus programs can
reduce pregnancy incidence; however, the direction of
ﬁndings consistently favoured abstinence-plus programs over
any controls. Programs had mixed effects on sexual behav-
iour: individual trials discovered protective effects on
incidence and frequency of unprotected vaginal, anal, and
oral sex; incidence and frequency of vaginal and anal sex;
incidence of any sexual activity; number of partners; number
of unprotected partners; condom use; and sexual initiation.
The trials that assessed HIV/AIDS knowledge found signiﬁ-
cant results favouring the majority of abstinence-plus
program participants over various controls. No adverse
effects were reported for any outcome.
Additional Results from Evaluations That Could Not
Be Obtained
At the time of this review, two replication trials of Be Proud!
Be Responsible! had been completed, but we were unable to
obtain complete results from conference presentations or the
authors in time for this review [140,141]. We do not believe
that including these trials would have changed our ﬁndings.
One unpublished trial encompassed ten arms (baseline
n ¼ 662), comparing an 8 h and a 12 h abstinence-plus
program to an abstinence-only program, a safer-sex program,
and an attention control at 24 mo follow-up (with and
without booster sessions for each condition) [141]. Prelimi-
nary ﬁndings showed no signiﬁcant differences in sexual
initiation among baseline virgins between the abstinence-plus
and the abstinence-only arms. Similar analyses of sexual
intercourse incidence among all participants appeared to
favour the abstinence-only intervention over the abstinence-
plus intervention arms, although signiﬁcance was marginal
(n , 336, p ¼ 0.05). Outcome data for all other comparisons,
including results for condom use and unprotected sex, were
unavailable. This trial is classiﬁed as ‘‘ongoing’’ in Figure 1, as
it was recently completed.
The other trial took place among slightly older adolescents
enrolled in ten US suburban high schools [140]. Preliminary
ﬁndings suggested no signiﬁcant behavioural effects at 1 y
follow-up when compared to an attention control [33], but
speciﬁc results were unavailable. This trial is classiﬁed as ‘‘full
text unavailable’’ in Figure 1.
Study Strengths
This is the ﬁrst review to our knowledge to focus exclusively
on abstinence-plus programs for HIV prevention among any
participants in high-income countries. Our review adds to
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of its international scope; prespeciﬁed, systematic, and highly
sensitive search for trial evidence; inclusion of published and
unpublished literature; extensive scrutiny of methodology of
included trials; exclusive focus on trials reporting behavioural
and biological outcomes; prereviewed protocol [41]; inde-
pendence from external funding; assessment of data on cost,
participant satisfaction, and program implementation; and
acceptance of only the most rigorous trial evidence (i.e., data
from randomized and quasi-randomized controlled trials).
This also is the ﬁrst review to our knowledge to extensively
search for abstinence-plus program trials from all high-income
countries. Our ﬁndings suggest that abstinence-plus program
trialsoutsideNorthAmericaarerareorinaccessiblebyexisting
search methods. We concur with past reviews indicating that
abstinence-based approaches are less common outside the US
[142,143]. Some abstinence-plus programs may be feasible
beyond North America; however, program implementers must
investigate program acceptability and rigorously compare
abstinence-plusprogramstoexistingHIVpreventionstrategies.
Generalisability and Study Limitations
These results may not generalize to all abstinence-plus
programs in all high-income settings. The included trials most
frequently evaluated community-based abstinence-plus pro-
gramsamongUSethnicminorityadolescentsfromlow-income
urban areas. However, application of this trial evidence in any
high-income setting must be considered carefully given
heterogeneity and the study limitations outlined above.
It was not possible to carry out subgroup analyses by
participant or study characteristics, although many of these
may be important confounders of program effects. Age may
be a particularly critical moderator: with mean ages ranging
from 11.3 to 19.3 y, trials enrolled participants in many stages
of sexual development, which might inﬂuence the way
abstinence-based messages were presented and received
across trials. It was also difﬁcult to conduct subgroup analyses
based on different program deﬁnitions of abstinence, as most
trials did not specify an exact deﬁnition.
Despite our extensive search for unpublished and ongoing
trials, publication bias and missed trials are always concerns
for systematic reviews. This review does not include studies
indexed after February 2007. We did not use a Bonferroni or
other correction to control for multiple statistical tests. The
results reported in this paper summarize 562 separate
statistical tests, of which 155 attained statistical signiﬁcance
at a level of p , 0.05 (far more than the 28 tests that may have
been expected to attain signiﬁcance by chance).
Perhaps owing to software limitations and lack of access to
the original data sets, our reanalyzed results differed slightly
from originally published results in trials by Boekeloo et al.
(incidence of vaginal sex [66]), Dancy et al. (sexual initiation
[70]), Jemmott et al. (incidence [78] and frequency [78,79] of
unprotected vaginal sex), Moberg et al. (sexual initiation [87]),
Sikkema et al. (condom use and sexual initiation [63]), St
Lawrence et al. (incidence of casual sex, knowledge [92]),
Villarruel et al. (incidence of vaginal sex [98]), and Wu et al.
(pregnancy and incidence of vaginal sex [64]). All but three
differences were in the direction of nonsigniﬁcant effects in
our reanalyzed version; reanalyzed results were signiﬁcant for
incidence of unprotected vaginal sex in one trial [78], condom
use in a second trial [63], and pregnancy in a third trial [64].
Methodological characteristics of the primary trials may
further affect the generalisability of our conclusions.
Strengths across trials included using relatively large sample
sizes, reporting long-term follow-up data, stating a theoretical
basis for the experimental intervention, describing the
development of data collection instruments, using techniques
to promote the validity of self-reported data, controlling for
baseline differences, and reporting the causes and possible
impacts of attrition. Deﬁciencies included the underreporting
of key methodological and statistical information, attrition
exceeding 33% in eight trials [63,64,68,69,81,82,99,100], lack
of controls for clustered randomization, self-reported out-
comes, vulnerability to ﬂoor effects, and insufﬁcient reporting
on program design and implementation. These deﬁciencies
mirrored limitations we observed in our review of abstinence-
only program trials [144].
Clinical Relevance
Despite these limitations, the evidence from this systematic
review has crucial implications for public health policy and
practice, particularly in the debate over abstinence-only and
abstinence-plus HIV prevention strategies. Our review of
abstinence-only programs [43,44] discovered 13 program
trials from eight papers [75,145–151], which enrolled 15,940
US adolescents. Trials consistently found no signiﬁcant
program effects on most biological and behavioural outcomes
when compared to various controls; isolated ﬁndings of
beneﬁt and harm were offset by nonsigniﬁcant ﬁndings in
other trials. In sum, the review suggested that abstinence-only
interventions do not signiﬁcantly decrease or exacerbate HIV
risk among high-income country participants.
In contrast, this review suggests that numerous abstinence-
plus interventions can have signiﬁcantly protective effects on
multiple sexual risk behaviours when compared to various
controls; furthermore, abstinence-plus programs did not have
adverse effects on behavioural or biological outcomes.
Participants appeared to understand the hierarchical mes-
sage of abstinence-plus programs, as trials consistently
reported signiﬁcant program effects for HIV prevention
knowledge. No trial observed adverse effects on incidence or
frequency of sexual activity, suggesting that safer sex
promotion did not encourage sex. Moreover, the promotion
of abstinence did not appear to detract from the programs’
condom promotion message: many trials found protective
short-term and long-term effects on condom use, and no trial
found an adverse effect.
Given that HIV risk in the US is elevated among low-
income and ethnic minority populations, we originally
planned to conduct subgroup analyses based on these
characteristics [41]. The lack of a quantitative synthesis made
these comparisons difﬁcult. However, protective behavioural
and biological program effects were frequently observed
among the 29 trials that enrolled primarily ethnic minority
participants [62–70,73,74,76–84,88–91,93,95,96,98,99], the 12
trials that enrolled primarily African-American participants
[62,64,70,73,74,76–79,91,95,96], and the 18 trials that reported
enrolling economically disadvantaged participants [62–
65,70,73,74,77–79,84,88–91,95,96,99]. Although these ﬁndings
cannot provide deﬁnitive conclusions about the moderating
effects of ethnicity or socioeconomic status, they suggest that
some abstinence-plus programs may be appropriate, accept-
able, and effective for underserved youth populations.
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While many trials in this review observed protective
behavioural or biological effects, more research is necessary
to understand what contexts, populations, and program
elements make these effects possible. Only one trial directly
compared an abstinence-plus against an abstinence-only or a
safer-sex intervention [75], and more comparisons of this
type may be necessary. Faith-based programs were not
represented, suggesting that they have not yet been evaluated
using rigorous methodology. Several evaluations found that
one version of an abstinence-plus program was more effective
than another, prompting research into intervention mecha-
nisms. Additional trials might also clarify program effects and
acceptability among non-North American youth and other
underrepresented groups (e.g., nonheterosexual youth, youth
with disabilities, or recent immigrants).
In future primary trials, key methodological, clinical, and
statistical information should be reported more completely
(i.e., following the CONSORT [Consolidated Standards of
Reporting Trials] statement [152]). To help policymakers and
practitioners, it is also necessary to report implementation
information fully for intervention and control arms. Clearer
reporting could help identify precisely which program
components were effective across trials. Data analyses should
account for dropouts, clustered randomization, and multiple
statistical tests, and data sets and intraclass correlation
coefﬁcients should be provided.
Finally, inconsistency in outcome measures across studies
suggests that trialists lack a standardized set of outcome
measures relevant to HIV risk. Consensus among HIV
prevention trialists is necessary to deﬁne relevant outcomes
with consistent recall periods and clinical meanings; this will
assist future research syntheses. Oral, anal, and vaginal sex
acts carry different HIV-related risks [153–155] and should be
evaluated separately. Same-sex sexual behaviours should also
be assessed. Medical assessments of STI and HIV incidence
are vital for understanding HIV risk, but these have been
severely underutilized to date. Even relatively small trials
should attempt to use biological end points, as the aggrega-
tion of small trials in a quantitative synthesis could overcome
the problem of ﬂoor effects. Recent studies in high-income
countries suggest that school-based STI screening is accept-
able among general adolescent populations [156,157], en-
couraging future efforts to evaluate biological end points
among young people.
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Background. Human immunodeficiency virus (HIV), which causes AIDS,
is most often spread through unprotected sex (vaginal, oral, or anal) with
an infected partner. Individuals can reduce their risk of becoming
infected with HIV by abstaining from sex or delaying first sex, by being
faithful to one partner or having few partners, and by always using a
male or female condom. Various HIV prevention programs targeted at
young people encourage these protective sexual behaviors. Abstinence-
only programs (for example, Project Reality in the US) present no sex
before marriage as the only means of reducing the risk of catching HIV.
Abstinence-plus programs (for example, the UK Apause program) also
promote sexual abstinence as the safest behavior choice to prevent HIV
infection. However, recognizing that not everyone will remain abstinent,
and that in many locations same-sex couples are not permitted to marry,
abstinence-plus programs also encourage young people who do
become sexually active to use condoms and other safer-sex strategies.
Safer-sex programs, a third approach, teach people how to protect
themselves from pregnancy and infections and might recommend
delaying first sex until they are physically and emotionally ready, but do
not promote sexual abstinence over safer-sex strategies such as condom
use.
Why Was This Study Done? There is considerable controversy,
particularly in the US, about the relative merits of abstinence-based
programs for HIV prevention. Abstinence-only programs, which the US
government supports, have been criticized because they provide no
information to protect participants who do become sexually active.
Critics of abstinence-plus programs contend that teaching young people
about safer sex undermines the abstinence message, confuses partic-
ipants, and may encourage them to become sexually active. Conversely,
some people worry that the promotion of abstinence might undermine
the safer-sex messages of abstinence-plus programs. Little has been
done, however, to look methodically at how these programs change
sexual behavior. In this study, the researchers have systematically
reviewed studies of abstinence-plus interventions for HIV prevention in
high-income countries to get an idea of their effect on sexual behavior.
What Did the Researchers Do and Find? In an extensive search for
existing abstinence-plus studies, the researchers identified 39 trials done
in high-income countries that compared the effects on sexual behavior
of various abstinence-plus programs with the effects of no intervention
or of other interventions designed to prevent HIV infection. All the trials
met strict preset criteria (for example, trial participants had to have an
unknown or negative HIV status), and all studies meeting the criteria
turned out to involve young people in the US, Canada, or the Bahamas,
nearly 40,000 participants in total. In 23 of the trials, the abstinence-plus
program studied was found to improve at least one self-reported
protective sexual behavior (for example, it increased abstinence or
condom use) when compared to the other interventions in the trial;
none of the trials reported a significant negative effect on any behavioral
outcome. Limited evidence from a few trials indicated that some
abstinence-plus programs reduced pregnancy rates, providing a bio-
logical indicator of program effectiveness. Conversely, there were no
indications of adverse biological outcomes such as an increased
occurrence of sexually transmitted diseases in any of the trials.
What Do These Findings Mean? These findings indicate that some
abstinence-plus programs reduce HIV risk behavior among young people
in North America. Importantly, the findings do not uncover evidence of
any abstinence-plus program causing harm. That is, fears that these
programs might encourage young people to become sexually active
earlier or confuse them about the use of condoms for HIV prevention
seem unfounded. These findings may not apply to all abstinence-plus
programs in high-income countries, do not include low-income
countries, do not specifically address nonheterosexual risk behavior,
and are subject to limited reliability in self-reporting of sexual activity by
young people. Nonetheless, this analysis provides support for the use of
abstinence-plus programs, particularly in light of another systematic
review by the same authors (A systematic review of abstinence-only
programs for prevention of HIV infection, published in the British Medical
Journal), which found that abstinence-only programs did not reduce
pregnancy, sexually transmitted diseases, or sexual behaviors that
increase HIV risk. Abstinence-plus programs, these findings suggest,
represent a reasonable strategy for HIV prevention among young people
in high-income countries.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040275.
  US National Institute of Allergy and Infectious Diseases fact sheet on
HIV infection and AIDS
  Information from the UK charity AVERT on all aspects of HIV and AIDS,
including HIV and AIDS prevention
  US Centers for Disease Control and Prevention fact sheet on HIV/AIDS
among young people (in English and Spanish)
  Information on Project Reality, a US abstinence-only program
  Information on Reducing the Risk and on Apause, US and UK
abstinence-plus programs, respectively
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